Expert Video - If I take part in a clinical trial for ovarian cancer, how will my safety be protected?
Jayanthi Lea, MD, of the University of Texas Southwestern Medical Center, discusses how clinical trial investigators work to protect patients and healthy volunteers from side effects or help them find alternative treatments. Dr. Lea describes how study monitors make sure the research is done correctly in clinical trials, and how trials can be stopped if there are problems. Dr. Lea also explains the importance of follow-up after a clinical trial, and how it helps investigators understand outcomes and any side effects. This helps protect volunteers and future patients who receive new ovarian cancer treatments.
This educational activity has been developed by the National Ovarian Cancer Coalition in collaboration with Mechanisms in Medicine Inc.
This activity is supported by educational grants from: Alkermes plc, AstraZeneca Pharmaceuticals LP, Clovis Oncology, Inc., Eisai Inc., Foundation Medicine, Inc., Genentech, a Member of the Roche Group, GSK, ImmunoGen, Inc., Merck & Co, Inc., Novartis, Novocure Inc., Pfizer, Inc.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.